Circulating cell-free DNA for cancer early detection

Q Gao, Q Zeng, Z Wang, C Li, Y Xu, P Cui, X Zhu, H Lu… - The Innovation, 2022 - cell.com
Effective screening modalities are currently available for only a small subset of cancers, and
they generally have suboptimal performance with complicated procedures. Therefore, there …

Anoikis-associated lung cancer metastasis: mechanisms and therapies

J Wang, Z Luo, L Lin, X Sui, L Yu, C Xu, R Zhang… - Cancers, 2022 - mdpi.com
Simple Summary Anoikis is a programmed cell death process resulting from the loss of
interaction between cells and the extracellular matrix. Therefore, it is necessary to overcome …

Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion

L Huang, L Zhang, X Chen - Briefings in bioinformatics, 2022 - academic.oup.com
MicroRNAs (miRNAs) are gene regulators involved in the pathogenesis of complex
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …

[HTML][HTML] SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection

Q Wang, ZH Gümüş, C Colarossi, L Memeo… - Journal of Thoracic …, 2023 - Elsevier
We review research regarding the epidemiology, risk factors, genetic susceptibility,
molecular pathology, and early detection of SCLC, a deadly tumor that accounts for 14% of …

The potential of using blood circular RNA as liquid biopsy biomarker for human diseases

G Wen, T Zhou, W Gu - Protein & cell, 2021 - academic.oup.com
Circular RNA (circRNA) is a novel class of single-stranded RNAs with a closed loop
structure. The majority of circRNAs are formed by a back-splicing process in pre-mRNA …

Artificial intelligence in lung cancer screening: the future is now

M Cellina, LM Cacioppa, M Cè, V Chiarpenello… - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is a widespread malignant tumour with a high mortality and
morbidity rate and is frequently diagnosed in the middle and late stages when few therapies …

[HTML][HTML] IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells

X Xu, J Cui, H Wang, L Ma, X Zhang, W Guo, X Xue… - Materials Today Bio, 2022 - Elsevier
A lack of promising targets leads to poor prognosis in patients with lung adenocarcinoma
(LUAD). Therefore, it is urgent to identify novel therapeutic targets. The importance of the N 6 …

Common diseases alter the physiological age-related blood microRNA profile

T Fehlmann, B Lehallier, N Schaum, O Hahn… - Nature …, 2020 - nature.com
Aging is a key risk factor for chronic diseases of the elderly. MicroRNAs regulate post-
transcriptional gene silencing through base-pair binding on their target mRNAs. We …

Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

C Palanca-Ballester, A Rodriguez-Casanova, S Torres… - Cancers, 2021 - mdpi.com
Simple Summary Apart from genetic changes, cancer is characterized by epigenetic
alterations, which indicate modifications in the DNA (such as DNA methylation) and histones …

Biomarkers and lung cancer early detection: state of the art

E Dama, T Colangelo, E Fina, M Cremonesi… - Cancers, 2021 - mdpi.com
Simple Summary Lung cancer is the leading cause of cancer death worldwide. Detecting
lung malignancies promptly is essential for any anticancer treatment to reduce mortality and …